ArticleEuropean urology oncology2018

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

Fern Anari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.